Jan Basile
About
Jan Basile is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery.
According to data from OpenAlex, Jan Basile has authored 150 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Cardiology and Cardiovascular Medicine, 46 papers in Endocrinology, Diabetes and Metabolism and 26 papers in Surgery. Recurrent topics in Jan Basile's work include Blood Pressure and Hypertension Studies (87 papers), Hormonal Regulation and Hypertension (24 papers) and Heart Rate Variability and Autonomic Control (16 papers). Jan Basile is often cited by papers focused on Blood Pressure and Hypertension Studies (87 papers), Hormonal Regulation and Hypertension (24 papers) and Heart Rate Variability and Autonomic Control (16 papers). Jan Basile collaborates with scholars based in United States, United Kingdom and Germany. Jan Basile's co-authors include Alan H. Gradman, George L. Bakris, Barry L. Carter, Brent M. Egan, William C. Cushman, Michael J. Bloch, Karen L. Margolis, Barry R. Davis, Gregory Wozniak and Nancy T. Artinian and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.
In The Last Decade
Jan Basile
141 papers receiving 2.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jan Basile United States | 28 | 1.8k | 949 | 548 | 377 | 241 | 150 | 3.0k | ||
| Vivencio Barrios Spain | 34 | 2.7k 1.5× | 905 1.0× | 902 1.6× | 361 1.0× | 254 1.1× | 353 | 4.1k | ||
| N. Poulter United Kingdom | 18 | 2.2k 1.2× | 709 0.7× | 505 0.9× | 300 0.8× | 433 1.8× | 57 | 3.3k | ||
| Isla S. Mackenzie United Kingdom | 31 | 2.2k 1.2× | 961 1.0× | 799 1.5× | 426 1.1× | 329 1.4× | 93 | 4.3k | ||
| Raymond O. Estacio United States | 27 | 2.3k 1.3× | 1.4k 1.5× | 457 0.8× | 276 0.7× | 260 1.1× | 57 | 3.9k | ||
| Charles E. Ford United States | 27 | 2.9k 1.6× | 1.1k 1.1× | 575 1.0× | 601 1.6× | 369 1.5× | 80 | 4.6k | ||
| Agustín J. Ramiréz Argentina | 20 | 2.4k 1.3× | 656 0.7× | 503 0.9× | 488 1.3× | 434 1.8× | 84 | 4.1k | ||
| Serap Erdine Türkiye | 25 | 2.5k 1.3× | 1.1k 1.2× | 1.0k 1.9× | 453 1.2× | 441 1.8× | 63 | 3.9k | ||
| Ettore Ambrosioni Italy | 28 | 2.6k 1.4× | 654 0.7× | 448 0.8× | 304 0.8× | 210 0.9× | 117 | 3.2k | ||
| Marion R. Wofford United States | 22 | 1.3k 0.7× | 858 0.9× | 356 0.6× | 292 0.8× | 314 1.3× | 37 | 3.3k | ||
| Elijah Saunders United States | 22 | 1.5k 0.8× | 791 0.8× | 280 0.5× | 353 0.9× | 383 1.6× | 57 | 2.4k |
Countries citing papers authored by Jan Basile
Since
Specialization
Citations
This map shows the geographic impact of Jan Basile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Basile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Basile more than expected).
Fields of papers citing papers by Jan Basile
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jan Basile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Basile. The network helps show where Jan Basile may publish in the future.
Co-authorship network of co-authors of Jan Basile
This figure shows the co-authorship network connecting the top 25 collaborators of Jan Basile. A scholar is included among the top collaborators of Jan Basile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Basile. Jan Basile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bloch, Michael J., Ajay J. Kirtane, Felix Mahfoud, et al.. (2024). 36-month durability of ultrasound renal denervation for hypertension resistant to combination therapy in RADIANCE-HTN TRIO. Hypertension Research. 47(12). 3467–3472.
2.
Franek, Edward, Prem Pais, Jan Basile, et al.. (2023). General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial. Cardiovascular Diabetology. 22(1). 52–52.
3.
Nicholls, Stephen J., Deepak L. Bhatt, John B. Buse, et al.. (2023). Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics. American Heart Journal. 267. 1–11.
4.
Gerstein, Hertzel C., Jan Basile, Ignacio Conget, et al.. (2022). A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes. Cardiovascular Diabetology. 21(1). 158–158.
5.
Bloch, Michael J., Ajay J. Kirtane, Felix Mahfoud, et al.. (2022). TCT-212 Twenty-Four Month Results in Patients With Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial. Journal of the American College of Cardiology. 80(12). B85–B86.
6.
Basile, Jan, Jiang He, Shawna D. Nesbitt, & Alan H. Gradman. (2018). Treating Special Populations with Hypertension: Is a Two-Drug or Fixed-Dose Combination Therapy Appropriate Initial Treatment in Hypertension?.
7.
Kirtane, Ajay J., Roland E. Schmieder, Felix Mahfoud, et al.. (2018). TCT-29 Procedural and anatomic predictors of response in RADIANCE-HTN SOLO: a multicenter, randomized, sham-controlled trial of endovascular ultrasound renal denervation. Journal of the American College of Cardiology. 72(13). B13–B13.
8.
Piller, Linda B., Lara M. Simpson, Sarah Baraniuk, et al.. (2014). Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHAT. Journal of General Internal Medicine. 29(11). 1475–1483.
9.
Fatemi, Omid, Eugene Yuriditsky, Costas Tsioufis, et al.. (2014). Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). The American Journal of Cardiology. 114(8). 1217–1222.
10.
Basile, Jan, et al.. (2011). Comparison of Aliskiren/Hydrochlorothiazide Combination Therapy With Hydrochlorothiazide Monotherapy in Older Patients With Stage 2 Systolic Hypertension: Results of the ACTION Study. Journal of Clinical Hypertension. 13(3). 162–169.
11.
Bloch, Michael J. & Jan Basile. (2010). Combination Angiotensin Receptor Blocker‐Neutral Endopeptidase Inhibitor Provides Additive Blood Pressure Reduction Over Angiotensin Receptor Blocker Alone. Journal of Clinical Hypertension. 12(10). 809–812.
12.
Basile, Jan. (2009). Antihypertensive therapy, new-onset diabetes, and cardiovascular disease. International Journal of Clinical Practice. 63(4). 656–666.
13.
Insull, William, Jan Basile, Anthony Vo, et al.. (2009). Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study. Journal of clinical lipidology. 3(2). 109–118.
14.
Basile, Jan. (2007). Recognizing the Link Between CKD and CVD in the Primary Care Setting: Accurate and Early Diagnosis for Timely and Appropriate Intervention. Southern Medical Journal. 100(5). 499–505.
15.
Miller, Peter M., Claudia Spies, Tim Neumann, et al.. (2006). Alcohol Biomarker Screening in Medical and Surgical Settings. Alcoholism Clinical and Experimental Research. 30(2). 185–193.
16.
Bloch, Michael J. & Jan Basile. (2006). Clinical insights into the diagnosis and management of atherosclerotic renal artery disease. Current Atherosclerosis Reports. 8(5). 412–420.
17.
Bloch, Michael J. & Jan Basile. (2006). Analysis of Recent Papers in Hypertension. Journal of Clinical Hypertension. 8(6). 452–454.
18.
Egan, Brent M., Jan Basile, Robert Ćhilton, & Jerome D. Cohen. (2005). Cardioprotection: The Role of β‐Blocker Therapy. Journal of Clinical Hypertension. 7(7). 409–416.
19.
Basile, Jan, et al.. (2004). A Statewide Primary Care Approach to Cardiovascular Risk Factor Control in High‐Risk Diabetic and Nondiabetic Patients With Hypertension. Journal of Clinical Hypertension. 6(1). 18–25.
20.
Bloch, Michael J. & Jan Basile. (2003). The Diagnosis and Management of Renovascular Disease: A Primary Care Perspective. Journal of Clinical Hypertension. 5(3). 210–218.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Vivencio Barrios Breakdown of academic impact, for papers by N. Poulter Breakdown of academic impact, for papers by Isla S. Mackenzie Breakdown of academic impact, for papers by Raymond O. Estacio Breakdown of academic impact, for papers by Charles E. Ford Breakdown of academic impact, for papers by Agustín J. Ramiréz Breakdown of academic impact, for papers by Serap Erdine Breakdown of academic impact, for papers by Ettore Ambrosioni Breakdown of academic impact, for papers by Marion R. Wofford Breakdown of academic impact, for papers by Elijah Saunders